SYDNEY LAHRE: Open Payments
NPI 1508555335 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 57 payments from 11 companies in 2025. Trend: 2023 $261 · 2024 $597 · 2025 $899
Food & beverage: $788Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $218 |
| E.R. Squibb & Sons, L.L.C. | 11 | $169 |
| ABBVIE INC. | 19 | $147 |
| Alkermes, Inc. | 4 | $97 |
| Janssen Pharmaceuticals, Inc | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $23 |
| Indivior Inc. | 1 | $18 |
Products named: COBENFY, VRAYLAR, ARISTADA, INVEGA SUSTENNA, REXULTI, AUSTEDO XR, Auvelity, UZEDY.
Industry payments across OH — which companies pay providers there.
